Accurate diagnosis and monitoring.

Undiagnosed, celiac disease can lead to long-term complications, and as many as 1 in 100 people worldwide are affected by the disease. That’s why we offer clinicians a comprehensive line of test options with QUANTA Lite®, QUANTA Flash®, and NOVA Lite® assays. Our tests include the most clinically relevant biomarkers to ensure accurate diagnosis and follow up testing, which may help patients avoid the long-term complications.

  • Patient care and comfort.
    With accurate testing, patients can be diagnosed faster and potentially avoid invasive procedures.
  • Confident lab technicians.
    With high­-quality tests that correlate with clinical disease parameters, labs can feel confident that they are reporting the most accurate results to clinicians.
  • Helping clinicians every step of the way.
    Using Deamidated Gliadin Peptide (DGP) and human tissue Transglutaminase (h­tTG) in combination can help stratify patients for biopsy or gluten free diet.